Top 5 Cannabis VC (Venture Capital) Funds in United Kingdom in January 2026

Last updated: Jan 2026 A list of 5 VC (Venture Capital) funds that invest in Cannabis startups based in United kingdom. We rank investors based on the number of investments they made in Cannabis companies from United kingdom. We update this investor list every month.

Top 5 Cannabis VC (Venture Capital) Funds in United Kingdom in January 2026

Investor	Cannabis United Kingdom investments
Deepbridge Capital	1
Measure 8 Venture Partners	1
Leafy Tunnel	1
Casa Verde Capital	1
Kindred Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Australia, Singapore

Portfolio highlights

AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.

Measure 8 Venture Partners, LP is an alternative investment vehicle created to capitalize on the emergence of the U.S. and global cannabis industry.

Investment focus

Cannabis, Alternative Medicine, Health Care
Funding Round, Seed, Convertible Note
United States, Germany, United Kingdom

Portfolio highlights

Neatleaf — Sustainable agriculture with optimal yields through data-driven understanding and comprehensive automation for everyone.
EMMAC Life Sciences — EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation, extraction, and production. It has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabisbut also as a European leader in the production and supply of medical cannabis, hemp, and other derivatives products.It was founded in 2018 and is headquartered in London, England.
Bloomwell Group — The Bloomwell Group provides easy access to natural-based medicine and with a patient-centric D2C approach, it mainly focuses on a strong and revolutionizing streamlined customer journey. Bloomwell Group is focusing on the treatment of chronic diseases with significantly fewer side effects than conventional medicine.

Leafy Tunnel is an early-stage venture capital firm investing in alternative medicine to address mental health and pain disorders.

Investment focus

Health Care, Medical, Cannabis
Seed, Series A
United States, United Kingdom

Portfolio highlights

Lyphe group — Lyphe Clinic - the leading UK medical cannabis clinic. Accessible, affordable, personalised treatment plans treatment with all appointments held online.
Maya Health — Maya Health is a psychedelic therapy software solution for researchers, providers, and participants. Click to learn more about how Maya can support you.
Ceretype Neuromedicine — Ceretype Neuromedicine is an AI-based fMRI brain biomarker technology to improve drug discovery and patient care. Based in Cambridge Massachusetts, Ceretype is founded on seminal scientific discoveries made in the laboratory of Emily Stern, David Silbersweig, and Hong Pan at Brigham and Women’s Hospital/Harvard Medical School (BWH/HMS).

As both the domestic and international markets continue to evolve and mature, Casa Verde maintains a view that cannabis will be among the most compelling investment themes of our generation.